Table 1.
Subjects (n = 16) | |
---|---|
Sex (M:F) | 4:12 |
Age (median [IQR]) | 27.5 [24.8–34.3] |
Vaccine manufacturer | |
Pfizer | 9 |
Moderna | 7 |
Race | |
White/Caucasian | 9 |
Asian | 6 |
Unspecified | 1 |
Antibiotic intake (past 3 months) | 2 |
Probiotic intake (past 2 weeks and/or currently) | 2 |
Blood sample collected for IgG titer post-dose 2 | 14 |
Matching stool samples collected at baseline, post-dose 1, and post-dose 2 | 16 |